نتایج جستجو برای: hepatocellular

تعداد نتایج: 54283  

Journal: :hepatitis monthly 0
shahrzad yazdanpanah department of pathology, shiraz university of medical sciences, shiraz, ir iran bita geramizadeh department of pathology, shiraz university of medical sciences, shiraz, ir iran; transplant research center, shiraz university of medical sciences, shiraz, ir iran; department of pathology, transplant research center, shiraz university of medical sciences, shiraz, ir iran. tel/fax: +98-7136473238 saman nikeghbalian transplant research center, shiraz university of medical sciences, shiraz, ir iran; department of surgery, hepatobiliary and liver transplant section, shiraz university of medical sciences, shiraz, ir iran seyed ali malek-hosseini transplant research center, shiraz university of medical sciences, shiraz, ir iran; department of surgery, hepatobiliary and liver transplant section, shiraz university of medical sciences, shiraz, ir iran

conclusions scc, lgdn, and hgdn are common associated findings and precursors of hcc in livers infected with hepatitis b. a strict follow-up and a precise and thorough sampling of livers with scc and any abnormal dysplastic nodules (dns), especially those larger than 1 cm, are highly recommended because these dns are highly associated with malignancy. results among all explanted cirrhotic liver...

Journal: :hepatitis monthly 0
zixiang zhu state key laboratory of veterinary etiological biology, national foot and mouth disease reference laboratory, lanzhou veterinary research institute, chinese academy of agricultural sciences, lanzhou, china xiangle zhang state key laboratory of veterinary etiological biology, national foot and mouth disease reference laboratory, lanzhou veterinary research institute, chinese academy of agricultural sciences, lanzhou, china guoqing wang college of veterinary medicine, gansu agricultural university, lanzhou, china haixue zheng state key laboratory of veterinary etiological biology, national foot and mouth disease reference laboratory, lanzhou veterinary research institute, chinese academy of agricultural sciences, lanzhou, china; corresponding author: haixue zheng, state key laboratory of veterinary etiological biology, national foot and mouth disease reference laboratory, lanzhou veterinary research institute, chinese academy of agricultural sciences, no. 1, xujiaping road, 730046, lanzhou, china. tel: +86-2134293139, fax: +86-9318342710

results researchers have reported that mirnas can repress the expression of important cancer-related genes and might be helpful in the diagnosis and treatment of cancer. during the past two decades, numerous studies have shown that mirnas play an essential role in inhibiting hcc via several different pathways. deregulated mirnas may contribute to carcinogenesis, indicating that mirnas can act a...

Journal: :hepatitis monthly 0
jennifer ng department of medicine, new york university langone medical center, united state jennifer wu division of hematology and medical oncology, new york university cancer institute, ny 10016, united state +1- 2122636485, [email protected]; division of hematology and medical oncology, new york university cancer institute, ny 10016, united state +1- 2122636485, [email protected]

context hepatitis b and hepatitis c (hbv and hcv) infections are both major causes of hepatocellular carcinoma (hcc). however, hcc caused by each of these two viruses has unique characteristics that should be studied independently to that of another one. while hbv- and hcv-related hccs share similar host and environmental risk factors such as male gender, age above 50 years old, family history ...

Journal: :مجله دانشگاه علوم پزشکی کرمانشاه 0
mahtab rahbar assistant professor in pathology, kermanshah university of medical sciences. ali asghar keshavarz assistant professor in internal medicine, kermanshah university of medical sciences shahla jahanbin senior resident in radiology, kermanshah university of medical sciences

introduction : fibrolamellar carcinoma (flc), a subtype of hepatocellular carcinoma (hcc), is a rare primary hepatic malignancy. several aspects of the clinical features and epidemiology of flc remain unclear since most literature on flc consists of case reports and small cases series with limited information on factors that affect survival. majority of the tumors occurred in patients less than...

Journal: :Journal of Biosciences and Medicines 2023

Hepatocellular carcinoma (HCC) is one of the common major malignancies worldwide and has third highest mortality rate any malignancy. The current field treatment for hepatocellular multidisciplinary in involvement a combination therapeutic approaches, among which immunotherapy modality advanced carcinoma. This review provides new ideas developing regimens improving efficacy patients with liver ...

Journal: :hepatitis monthly 0
olfat hammam departments of pathology, theodor bilharz research institute, egypt ola mahmoud departments of hematology, theodor bilharz research institute, no. 1 sharara building, hassan elmamoun st., nasr city, egypt +20-224723116, [email protected]; departments of hematology, theodor bilharz research institute, no. 1 sharara building, hassan elmamoun st., nasr city, egypt +20-224723116, [email protected] manal zahran departments of hematology, theodor bilharz research institute, no. 1 sharara building, hassan elmamoun st., nasr city, egypt +20-224723116, [email protected] sohair aly malaysia and medicinal chemistry department, advanced dental and medical institute, ippt, usm, nrc, egypt karim hosny surgical department, kasr el aini hospital, egypt amira helmy departments of electron microscopy, theodor bilharz research institute, egypt

background the fas receptor/ligand system including soluble forms is the most important apoptotic initiator in the liver. dysregulation of this pathway may contribute to abnormal cell proliferation and cell death and is regarded as one of the mechanisms preventing the immune system from rejecting the tumor cells. objectives to analyze the role of fas system fas/ fas ligand (fas/ fasl) in the mu...

Journal: :hepatitis monthly 0
zeinab fazeli proteomics research center, students’ research committee, shahid beheshti university of medical sciences, ir iran mohsen vahedi department of epidemiology and biostatistics, school of public health, tehran university of medical sciences, ir iran sara ashtari department of health system research, gastroenterology and liver disease research center, shahid beheshti university of medical sciences, ir iran +98-2122432515, [email protected] mohamad amin pourhoseingholi department of health system research, gastroenterology and liver disease research center, shahid beheshti university of medical sciences, ir iran +98-2122432515, [email protected]; department of health system research, gastroenterology and liver disease research center, shahid beheshti university of medical sciences, ir iran +98-2122432515, [email protected]

Journal: :hepatitis monthly 0
hui xu department of medical laboratory, xiangya medial school, central south university (csu), changsha, china xia gong department of medical laboratory, xiangya medial school, central south university (csu), changsha, china hui hui zhang department of medical laboratory, xiangya medial school, central south university (csu), changsha, china qin zhang department of medical laboratory, xiangya medial school, central south university (csu), changsha, china dandan zhao department of medical laboratory, xiangya medial school, central south university (csu), changsha, china jian xiong peng department of medical laboratory, xiangya medial school, central south university (csu), changsha, china; department of medical laboratory, xiangya medial school, central south university (csu), changsha, china. tel: +88-60731-82650279

background human telomerase reverse transcriptase (htert) has become an ideal target for development of anticancer therapy. small interfering rnas (sirnas) are very powerful reagents for gene silencing and show promise for cancer gene therapy. however, only a small number of sirnas have been demonstrated to be effective. for gene therapy targeting htert, it is essential to develop a robust syst...

Journal: :hepatitis monthly 0
ying feng department of general surgery, nantong university affiliated hospital, nantong, china peng li department of general surgery, nantong university affiliated hospital, nantong, china yifei liu department of pathology, nantong university affiliated hospital, nantong, china zhenyu sha department of medical affairs, nantong university affiliated hospital, nantong, china liang feng department of general surgery, nantong university affiliated hospital, nantong, china fei wang department of general surgery, nantong university affiliated hospital, nantong, china

conclusions the polymorphism and promoter methylation of rassf1a may be a significant factor in hcc, and can be an indicator for poor prognosis in patients with hcc. background the functional and prognostic significance of ras association domain family 1a gene (rassf1a) on hepatocellular carcinoma (hcc) has not been well characterized. objectives this study aimed to investigate the association ...

Journal: :hepatitis monthly 0
fatemeh zare gastroenterohepatology research center, shiraz university of medical sciences, shiraz, ir iran mohammad reza fattahi gastroenterohepatology research center, shiraz university of medical sciences, shiraz, ir iran; gastroenterohepatology research center, research tower, nemazee hospital, shiraz university of medical sciences, shiraz, ir iran. tel/fax: +98-7136281442 masood sepehrimanesh gastroenterohepatology research center, shiraz university of medical sciences, shiraz, ir iran ali reza safarpour gastroenterohepatology research center, shiraz university of medical sciences, shiraz, ir iran

conclusions chronic hepatitis c-related liver diseases impose a substantial economic burden on patients, families and the society. the current study provides useful information on cost of treatment and work loss for different disease states, which can be further used in cost-effectiveness evaluations. results the total annual cost per patient for chronic hepatitis c, cirrhosis and hepatocellula...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید